Innovative Cellular Therapeutics Holdings reports Lyell Immunopharma common share disposal worth $137.3
LYEL•Lyell Immunopharma 10% owner sells 10 common shares
- Lyell Immunopharma 10% owner Innovative Cellular Therapeutics Holdings Ltd sold 10 common shares on July 16, 2026.
- Shares were sold at USD 13.73, cutting holdings to 2,857,490 common shares.
